增加棕提取物剂量对下泌尿道症状的影响:一项随机试验
Michael J Barry1, Sreelatha Meleth, Jeannette Y Lee
1Department of Medicine, Massachusetts General Hospital, 50 Staniford St, Ninth Floor, Boston, MA 02114, USA. mbarry@partners.org
JAMA
|September 29, 2011
概括
与安慰剂相比,较高剂量的棕提取物在患有良性前列腺增生症 (BPH) 的男性中没有改善下尿路症状. 这项随机试验没有发现显著的疗效,即使是标准剂量的三倍.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 棕果提取物通常用于与良性前列腺增生 (BPH) 相关的下泌尿道症状 (LUTS).
- 最近的研究提出了关于标准剂量 (320毫克/天) 棕的疗效的问题.
研究的目的:
- 为了研究增加剂量棕提取物 (Serenoa repens) 对BPH男性LUTS的影响.
- 评估剂量高达标准320毫克/天的三倍.
主要方法:
- 这是一项双盲,多中心,安慰剂对照的随机试验,涉及369名45岁以上的男性,患有与BPH相关的LUTS.
- 参与者在72周内接受了棕提取物或安慰剂的升级剂量.
- 主要结局是美国泌尿病学会症状指数 (AUASI) 评分从基线到72周的变化.
主要成果:
- 棕树提取物和安慰剂组都显示了平均AUASI分数的下降.
- 在AUASI得分变化中,看棕树提取物和安慰剂组之间没有统计学上显著的差异.
- 棕提取物在任何次要结局指标上都没有表现出比安慰剂更高的疗效,没有发现任何显著的不良影响.
结论:
- 与安慰剂相比,增加棕果提取物剂量并没有为下尿路症状提供更大的缓解.
- 这些发现不支持使用更高剂量的棕树来管理与BPH相关的LUTS.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
773
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
773
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
354
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
354
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
409
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
409
Urinary Tract Calculi III: Medical Management
354
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
354


